Australia markets closed

Greenwich LifeSciences, Inc. (GLSI)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
12.89-0.16 (-1.23%)
At close: 04:00PM EDT
12.89 0.00 (0.00%)
After hours: 06:17PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 166.00M
Enterprise value 159.01M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)24.78
Enterprise value/revenue N/A
Enterprise value/EBITDA -17.05

Trading information

Stock price history

Beta (5Y monthly) 3.19
52-week change 312.18%
S&P500 52-week change 321.23%
52-week high 321.44
52-week low 37.58
50-day moving average 314.91
200-day moving average 310.95

Share statistics

Avg vol (3-month) 350.85k
Avg vol (10-day) 336.58k
Shares outstanding 512.88M
Implied shares outstanding 612.88M
Float 85.83M
% held by insiders 152.58%
% held by institutions 14.86%
Shares short (28 Mar 2024) 4140.46k
Short ratio (28 Mar 2024) 42.4
Short % of float (28 Mar 2024) 42.29%
Short % of shares outstanding (28 Mar 2024) 41.09%
Shares short (prior month 29 Feb 2024) 4121.26k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-56.96%
Return on equity (ttm)-89.30%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -9.32M
Net income avi to common (ttm)-8.89M
Diluted EPS (ttm)-0.69
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)6.99M
Total cash per share (mrq)0.54
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)23.74
Book value per share (mrq)0.52

Cash flow statement

Operating cash flow (ttm)-6.48M
Levered free cash flow (ttm)-3.42M